
How drug companies distort medical evidence, starting with unpublished trials.
Trial design, publication bias and regulatory failure.
Goldacre, a physician and epidemiologist, sets out how the evidence base for medicine is distorted, working through the drug development and publication pipeline stage by stage.
His central charge is publication bias. Trials with negative results are systematically less likely to be published, which means the published literature overstates the effectiveness of treatments even when every individual study is honest. He documents the scale of missing trial data, the failed attempts to establish registration requirements, and the cases including Tamiflu and Study 329 on paroxetine in adolescents where withheld data reversed the apparent conclusion.
He then covers the other distortions: trials designed with the wrong comparator, the wrong dose of the comparator, surrogate endpoints rather than outcomes patients care about, populations selected to maximise the chance of a positive result, and durations too short to show harms. He covers the regulatory approval process and the fact that regulators hold data they do not release. He covers ghostwriting of academic papers, the payment of key opinion leaders, the marketing of medical education, and the effect of pharmaceutical representatives on prescribing.
Goldacre is precise about what is illegal, what is legal and what is simply a structural consequence of who funds the research. The book is written accessibly and is carefully sourced.
It is from 2012 and there have been real changes since, including the AllTrials campaign it launched, mandatory registration requirements and improved data access. The problems it documents have been reduced rather than resolved.
Healthcare investors and operators who need to understand what published clinical evidence does and does not establish.
Chosen by shared topics, the entries that hold them, and the people who recommended both.
A doctor's exposé of bad science in medicine, the media and alternative cures.
“I think there's a book called Bad Science by Ben Goldacre, who's an MD from the UK. There are a number of chapters that are not relevant to US audience, but it's a helpful book for teaching yourself to think in a structured way, scientifically about medicine.” — Tim Ferriss
Source: The Tim Ferriss Show Transcripts: Dr. Andrew Huberman — Peptides, Performance, and Protocols (#876)
Recommended by: Tim Ferriss
Fraud in data and manufacturing at offshore generic-drug plants.
Three generations of the Sackler family and how Purdue Pharma sold OxyContin.
How Genentech turned genetic engineering into a company, from its founders' accounts.
Recommended by: Laura Deming, Patrick Collison
Inside Vertex's first years: how a new drug company tries to discover a drug.
Recommended by: Laura Deming
A biography of cancer, by a physician and oncologist.
“I loved Mukherjee's 2015 TED Talk and his brilliant book about cancer, The Emperor of All Maladies, which won the Pulitzer Prize in 2011.” — Bill Gates
Source: My thoughts on 'The Gene: An Intimate History' — Gates Notes
Recommended by: Bill Gates, Andrew Chen, Laura R Walker and 1 other
As an Amazon Associate I earn from qualifying purchases.